Your shopping cart is currently empty

Idoxifene (CB7432) is a selective and tissue-specific estrogen receptor modulator (SERM) that reduces collagen and malondialdehyde (MDA) levels in rat liver, exhibiting anti-fibrotic effects.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $68 | - | In Stock | |
| 5 mg | $163 | - | In Stock | |
| 10 mg | $289 | - | In Stock | |
| 25 mg | $619 | - | In Stock | |
| 50 mg | $1,070 | - | In Stock | |
| 100 mg | $1,820 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $189 | - | In Stock |
| Description | Idoxifene (CB7432) is a selective and tissue-specific estrogen receptor modulator (SERM) that reduces collagen and malondialdehyde (MDA) levels in rat liver, exhibiting anti-fibrotic effects. |
| In vitro | In vascular smooth muscle cells, Idoxifene inhibits Angiotensin II-induced reactive oxygen species (ROS) production [1]. In cultured activated hepatic stellate cells, Idoxifene dose-dependently inhibits activation and proliferation while time-dependently inducing apoptosis [1]. Idoxifene acts as an estrogen receptor agonist on osteoblasts in bone and exhibits weak agonist activity in human endometrial cells. Idoxifene and estradiol (E2) protect hepatocytes from inflammatory cell damage by inhibiting NF-κB activation [2]. |
| In vivo | Following DMN treatment, rats administered daily intraperitoneal estradiol (0.5 mg/kg) alongside Idoxifene (0.1 and 0.5 mg/kg; oral) for 3 days exhibited dose-dependent reductions in liver collagen and malondialdehyde (MDA) levels, demonstrating antifibrotic effects [2]. |
| Synonyms | CB7432 |
| Molecular Weight | 523.45 |
| Formula | C28H30INO |
| Cas No. | 116057-75-1 |
| Smiles | C(=C(/CC)\C1=CC=CC=C1)(\C2=CC=C(OCCN3CCCC3)C=C2)/C4=CC=C(I)C=C4 |
| Relative Density. | 1.329g/cm3 |
| Storage | keep away from moisture,keep away from direct sunlight | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 40 mg/mL (76.42 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.